Today’s stock pick update – Open Now

Learn More Could This Tiny $2 Stock Be Apple's Next Takeover? It trades for just $2 per share... Its 'gatekeeper' technology holds hostage the entire $12 Trillion 5G revolution... It just secured a CRITICAL 5G patent... And by October 1st, my research says a major smartphone player could buy out this tiny company and hand us a FAST FORTUNE!(Ad) Click here for the full story >> Oracle Is Now In The Running To Buy TikTok’s U.S. Operations

Senate Republicans are planning to introduce a scaled-back stimulus bill amid the standoff with Democrats over a new virus relief plan that has dragged on for weeks. The legislation would include just $300 a week in enhanced unemployment benefits through December 27, money for small business aid, additional funding for the U.S. Postal Service, and protection for employers against lawsuits stemming from COVID-19infections. The bill represents a slimmed-down version of the $1 t... Read More

Myovant Sciences (NYSE: MYOV): Myovant Sciences shares got a boost this week after the company announced yesterday that its New Drug Application for once-daily, oral relugolix combination tablet had been accepted for review with the FDA. “Relugolix is now under FDA review for two distinct potential new treatment options in uterine fibroids and advanced prostate cancer, indication... Read More

CVS’ bargain status gets better every quarter The reality is that states continue to struggle to manage reopening economic, civic, and social activity, so there remains a long road ahead before concerns about coronavirus, and its effects on individuals, families, and organizations of every type are behind us. On an individual level, that means that a big part of the onus is on each of us to see to our own well-being, and that of our loved ones. I think that means, at least in part, that pharmacies are going to continue to be star perform... Read More

Featured Stock Surface Oncology, Inc. (SURF) – Buy Price: $6.50 or better Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies. The company develops human immunoglobulin isotype G4 monoclonal antibodies, including SRF231 inhibiting CD47; NZV930 inhibiting CD73; SRF617 inhibiting CD39; SRF388 targeting interleukin 27; and SRF813 targeting CD112R. It also develops various earlier stage programs that targets other critical components of the tumor microenvironment, including regulatory T cells and natural kill... Read More

Other Top Stories Postal Service leader halts some operational changes amid outcry over mail delays before election Carnival Corp. hacked; guest and worker information accessed Greece: EU must step up response to Turkey's 'aggression' Clarification: Greece-Airport Development story Dining out: 35 million meals claimed in UK discount plan

Trend Following Picks Surface Oncology, Inc. (SURF) – Buy Price: $6.50 or better Genprex, Inc. (GNPX) – Buy Price: $4.50 or better PAVmed Inc. (PAVM) – Buy Price: $2.25 or better Ovid Therapeutics Inc. (OVID) – Buy Price: $8.00 or better ACM Research, Inc. (ACMR) – Buy Price: $106.00 or better All Picks

Reversal Picks Netflix, Inc. (NFLX)- Buy Target: $508.12 – Sell Target: $533.80 Seagate Technology plc (STX) – Buy Target: $46.42 – Sell Target: $51.11 Cytokinetics, Incorporated (CYTK) – Buy Target: $22.94 – Sell Target: $26.07 The Alkaline Water Company Inc. (WTER) – Buy Target: $1.84 – Sell Target: $2.22 Relmada Therapeutics, Inc. (RLMD) Buy Target – $39.62 – Sell Target – $46.81 All Picks

Low Price Stock Picks Western Copper and Gold Corporation (WRN) Innovation Pharmaceuticals Inc. (IPIX) Golden Minerals Company (AUMN) International Tower Hill Mines Ltd. (THM) Akari Therapeutics, Plc (AKTX) All Picks

Already subscribed to our premium service? Click here to Login. Not a TradersPro subscriber yet? Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits

This email was sent to phanhoa1821960.trader@blogger.com  by TradersPro Investiv, LLC 265 N. Main | Ste. D #283 Kaysville | UT | 84037 Forward to a friend | Unsubscribe or Mange which emails you get from TradersPro   All trading carries significant risk. Please see our full risk disclaimer. Disclaimers, Terms & Conditions | Privacy Policy Copyright © 2020